Pharmaceuticals

Motions to Dismiss Filed in Alleged Insulin Price...

On Wednesday in the District of New Jersey, two motions to dismiss were...

Eli Lilly Says Feds Have Overstepped Authority to...

On Tuesday in the Southern District of Indiana, plaintiffs Eli Lilly and Company and...

Pfizer Accuses Aurobindo of Infringing on Rheumatoid Arthritis...

Yesterday, Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V., PBG Puerto Rico LLC,...

Neuroscience Company Facing Securities Suit After Allegedly Misleading...

Minerva Neuroscience is facing a putative class-action securities lawsuit filed by an investor in...

Pharmaceutical Manufacturer Produced COVID-19 Treatments but was Never...

Aurigene Pharmaceutical Services Ltd. (APSL) filed suit against ViralClear Pharmaceuticals, Inc. (ViralClear) and BioSig...

Parties Argue Whether Court Should Remand, Transfer, or...

On Wednesday, Celgene Corporation and its parent Bristol Myers Squibb Company filed an opposition...

Federal Circuit Sides with District Court, Rules Pharma...

On Wednesday, an opinion was issued in a Federal Circuit case brought by Horizon...

Proposed DEA Rule Would Eliminate Paper Registration Applications

The Drug Enforcement Administration (DEA) proposed a rule on Thursday that would amend regulations...